您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Uprosertib(GSK2141795)HCl
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Uprosertib(GSK2141795)HCl
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Uprosertib(GSK2141795)HCl图片
CAS NO:1047635-80-2
规格:≥98%
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
250mg电议
500mg电议

产品介绍
理化性质和储存条件
Molecular Weight (MW)465.71
FormulaC18H17Cl3F2N4O2
CAS No.1047635-80-2 (Uprosertib HCl);
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: ≥ 150 mg/mL
Water: N/A
Ethanol: N/A
SMILESO=C(C1=CC(C2=C(Cl)C=NN2C)=C(Cl)O1)NC(CN)CC3=CC=C(F)C(F)=C3.[H]Cl
SynonymsUprosertib HCl; GSK2141795 HCl; GSK2141795 Hydrochloride; GSK 2141795; GSK795; GSK795; GSK 795
实验参考方法
In Vitro

Kinase Assay: For selectivity profiling experiments, the lysates (5 mg of total protein each) are preincubated with 0 (DMSO control), 2.5 nM, 25 nM, 250 nM, 2.5 μM or 25 μM free compound (GSK690693 or GSK2141795) on an end-over-end shaker for 45 min at 4°C. Subsequently, lysates are incubated with beads (coupled Akt probe or kinobeads) for 1 h at 4°C, for both qualitative and quantitative experiments. The beads are washed with 1×CP buffer and collected by centrifugation. Bound proteins are eluted with 2×NuPAGE LDS sample buffer, and eluates are reduced and alkylated by 50 mM dithiothreitol and 55 mM iodoacetamide.


Cell Assay: Cells were washed in ice-cold tris buffered saline (TBS), spun down and lysed in radioimmunoprecipitation assay buffer (10 mM Tris HCl, pH 8, 5 mM Na2EDTA, pH 8, 1% NP-40, 0.5% sodium dioxycholate, 0.1% SDS), both containing protease and phosphatase inhibitors (Complete Mini PhosphoSTOP, Roche, Basel, Switzerland). Protein concentrations were determined by Pierce BCA Protein Assay (Thermo Fisher Scientific, Rockford, IL, USA) according to the manufacturer’s protocol. 5–40 μg protein was resolved on 4–12% RunBlue SDS-PAGE gels (Expedeon, San Diego, CA, USA), transferred onto PVDF membrane (GE Healthcare Life Sciences, Buckinghamshire, UK), blocked and then incubated with primary monoclonal antibodies ON at 4 °C. Following, the membranes were incubated with goat anti-rabbit, goat anti-mouse (#P0448, #P0447, Dako, Glostrup, Denmark) or donkey anti-goat (#SC-2020, Santa Cruz Biotechnology, Heidelberg, Germany) HRP-conjugated secondary antibodies in 1:5000 dilution for 1 h at room temperature (RT). The immune reactive bands were visualized by Amersham ECL Prime Western Blotting Detecting Reagent (GE Healthcare Life Sciences) and exposed to CL-Xposure film (Thermo Fisher Scientific).

In VivoAll animal experiments were approved by The Experimental Animal Committee of The Danish Ministry of Justice and were performed at the animal core facility at University of Southern Denmark. Mice were housed under pathogen-free conditions with ad libitum food and water. Subconfluent PC9-ER cells (1.5 x 106) were harvested using accutase and resuspended in a 1:1 mixture of extracellular matrix from Engelbreth-Holm-Swarm sarcoma (Sigma-Aldrich) and RPMI1640 media, and injected subcutaneously into 16-week-old female CB17 SCID mice (Taconic, Ejby, Denmark). When tumors reached a palpable diameter of 2–3 mm, mice were randomized into groups of n = 9 per group. Animals were euthanized if they showed any adverse signs of disease including weight loss, paralysis, thymus dysfunction, or general discomfort. Accordingly, eight mice were censored during the course of the study. Erlotinib HCl was formulated at 25 μg/g bodyweight in 15% Captisol (La Jolla, CA, USA). GSK2141795 was formulated at 10 μg/g bodyweight in DMSO. 15% Captisol was used as vehicle, and the concentration of DMSO did not exceed 10% when administered. Drugs were administered 5 days a week for 3 weeks by oral gavage. Maximum volume per mouse was 200 μL. Tumor volume and bodyweight were surveyed during the extent of the study. Tumor volume was measured with calipers and calculated according to: tumor volume (mm3) = (length×width2)/2.
Animal modelFemale CB17 SCID mice
Formulation & DosageGSK2141795 was formulated at 10 μg/g bodyweight in DMSO.; 10 μg/g bodyweight; p.o.
ReferencesNat Commun. 2017 Sep 4;8(1):410. doi: 10.1038/s41467-017-00450-6; J Proteome Res. 2013 Aug 2;12(8):3792-800